TY - JOUR
KW - British Columbia/epidemiology
KW - Drug Overdose/drug therapy/epidemiology
KW - Female
KW - Humans
KW - Illicit drugs
KW - Male
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Harm Reduction
KW - naloxone
KW - Opioid antagonist
KW - Overdose
KW - take-home naloxone
KW - Toxicity
AU - V. Lei
AU - M. Ferguson
AU - R. Geiger
AU - S. Williams
AU - L. Liu
AU - J. A. Buxton
A1 - 
AD - School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.; BC Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.; BC Centre for Disease Control, Vancouver, BC, Canada.; BC Centre for Disease Control, Vancouver, BC, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. jane.buxton@bccdc.ca.; BC Centre for Disease Control, Vancouver, BC, Canada. jane.buxton@bccdc.ca.
BT - Substance abuse treatment, prevention, and policy
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
DO - 10.1186/s13011-022-00452-8
IS - 1
JF - Substance abuse treatment, prevention, and policy
LA - eng
M1 - Journal Article
PB - . The Author(s)
PY - 2022
SN - 1747-597X; 1747-597X
SP - 25
T1 - Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data
T2 - Substance abuse treatment, prevention, and policy
TI - Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data
U1 - Education & Workforce; Opioids & Substance Use
U2 - 35361228
U3 - 10.1186/s13011-022-00452-8
VL - 17
VO - 1747-597X; 1747-597X
Y1 - 2022
Y2 - Mar 31
ER -